Modelling of the SDF-1/CXCR4 regulated in vivo homing of therapeutic mesenchymal stem/stromal cells in mice.

Wang Jin,Anastasia Brooks,Xin Liu,Haolu Wang,Michael R Doran,Michael S Roberts,Kathryn Futrega,Matthew J Simpson,Xiaowen Liang

doi:10.7717/peerj.6072

Abstract

BackgroundMesenchymal stem/stromal cells (MSCs) are a promising tool for cell-based therapies in the treatment of tissue injury. The stromal cell-derived factor-1 (SDF-1)/CXC chemokine receptor 4 (CXCR4) axis plays a significant role in directing MSC homing to sites of injury. However in vivo MSC distribution following intravenous transplantation remains poorly understood, potentially hampering the precise prediction and evaluation of therapeutic efficacy.MethodsA murine model of partial ischemia/reperfusion (I/R) is used to induce liver injury, increase the hepatic levels of SDF-1, and study in vivo MSC distribution. Hypoxia-preconditioning increases the expression of CXCR4 in human bone marrow-derived MSCs. Quantitative assays for human DNA using droplet digital PCR (ddPCR) allow us to examine the in vivo kinetics of intravenously infused human MSCs in mouse blood and liver. A mathematical model-based system is developed to characterize in vivo homing of human MSCs in mouse models with SDF-1 levels in liver and CXCR4 expression on the transfused MSCs. The model is calibrated to experimental data to provide novel estimates of relevant parameter values.ResultsImages of immunohistochemistry for SDF-1 in the mouse liver with I/R injury show a significantly higher SDF-1 level in the I/R injured liver than that in the control. Correspondingly, the ddPCR results illustrate a higher MSC concentration in the I/R injured liver than the normal liver. CXCR4 is overexpressed in hypoxia-preconditioned MSCs. An increased number of hypoxia-preconditioned MSCs in the I/R injured liver is observed from the ddPCR results. The model simulations align with the experimental data of control and hypoxia-preconditioned human MSC distribution in normal and injured mouse livers, and accurately predict the experimental outcomes with different MSC doses.DiscussionThe modelling results suggest that SDF-1 in organs is an effective in vivo attractant for MSCs through the SDF-1/CXCR4 axis and reveal the significance of the SDF-1/CXCR4 chemotaxis on in vivo homing of MSCs. This in vivo modelling approach allows qualitative characterization and prediction of the MSC homing to normal and injured organs on the basis of clinically accessible variables, such as the MSC dose and SDF-1 concentration in blood. This model could also be adapted to abnormal conditions and/or other types of circulating cells to predict in vivo homing patterns.

Highlights

Mesenchymal stem/stromal cells (MSCs) are excellent candidates for use in tissue repair and regeneration (Fu et al, 2018; Niclis et al, 2017; Squillaro, Peluso & Galderisi, 2016; Zhang et al, 2017)
To elucidate the stromal cell-derived factor1 (SDF-1)/CXC chemokine receptor 4 (CXCR4) regulated in vivo homing of human MSCs, we use droplet digital PCR assays for human-specific Alu sequences to quantify the numbers MSCs in the blood and liver of normal and hepatic I/R injured mice (Figs. 2D and 2E)
Aligning with these experimental findings, our droplet digital PCR (ddPCR) results show an increased number of hypoxia-preconditioned MSCs in the I/R injured liver comparing to the normal MSCs in the same liver condition

Summary

Introduction

Mesenchymal stem/stromal cells (MSCs) are excellent candidates for use in tissue repair and regeneration (Fu et al, 2018; Niclis et al, 2017; Squillaro, Peluso & Galderisi, 2016; Zhang et al, 2017). The stromal cell-derived factor (SDF-1)/CXC chemokine receptor 4 (CXCR4) axis plays a significant role in directing MSC homing to sites of injury. Hypoxia-preconditioning increases the expression of CXCR4 in human bone marrowderived MSCs. Quantitative assays for human DNA using droplet digital PCR (ddPCR) allow us to examine the in vivo kinetics of intravenously infused human MSCs in mouse blood and liver. A mathematical model-based system is developed to characterize in vivo homing of human MSCs in mouse models with SDF-1 levels in liver and CXCR4 expression on the transfused MSCs. The model is calibrated to experimental data to provide novel estimates of relevant parameter values. The model simulations align with the experimental data of control and hypoxia-preconditioned human MSC distribution in normal and injured mouse livers, and accurately predict the experimental outcomes with different MSC doses.

Methods

Results

Conclusion